Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS-Reference-Cited by-同舟云学术

Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS

Published:2014-12-11 Issue:25 Volume:124 Page:3817-3827
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Kanakry Christopher G.¹,Tsai Hua-Ling¹,Bolaños-Meade Javier¹,Smith B. Douglas¹,Gojo Ivana¹,Kanakry Jennifer A.¹,Kasamon Yvette L.¹,Gladstone Douglas E.¹,Matsui William¹,Borrello Ivan¹,Huff Carol Ann¹,Swinnen Lode J.¹,Powell Jonathan D.¹,Pratz Keith W.¹,DeZern Amy E.¹,Showel Margaret M.¹,McDevitt Michael A.¹,Brodsky Robert A.¹,Levis Mark J.¹,Ambinder Richard F.¹,Fuchs Ephraim J.¹,Rosner Gary L.¹,Jones Richard J.¹,Luznik Leo¹

Affiliation:

1. Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD

Abstract

Key Points Posttransplantation cyclophosphamide is effective as sole GVHD prophylaxis for myeloablative HLA-matched–related or –unrelated BMT. Despite low chronic GVHD with PTCy, relapse and survival are comparable with outcomes reported using other GVHD prophylactic approaches.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/124/25/3817/1465180/3817.pdf

Reference53 articles.

1. Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation.;Weiden;N Engl J Med,1981

2. Graft-versus-leukemia reactions after bone marrow transplantation.;Horowitz;Blood,1990

3. Graft-versus-host disease induced graft-versus-leukemia effect: greater impact on relapse and disease-free survival after reduced intensity conditioning.;Weisdorf;Biol Blood Marrow Transplant,2012

4. Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study.;Bhatia;Blood,2007

5. Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation.;Ratanatharathorn;Blood,1998

Cited by 153 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post-transplantation cyclophosphamide as GVHD prophylaxis in allogenic hematopoietic stem cell transplantation: Recent advances and modification;Blood Reviews;2023-11

2. Dynamics of polyclonal immuno-reconstitution after allogeneic transplant with post-transplant cyclophosphamide and letermovir;Bone Marrow Transplantation;2023-07-19

3. Cyclophosphamide with cyclosporine A for graft-versus-host disease prophylaxis in adult patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation from human leucocyte antigen-matched donors;International Immunopharmacology;2023-07

4. Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis;New England Journal of Medicine;2023-06-22

5. Extracorporeal Photopheresis as Graft-versus-Host Disease Prophylaxis: A Randomized Controlled Trial;Transplantation and Cellular Therapy;2023-06